|
Volume 270,
Number 41,
Issue of October 13, 1995 pp. 24292-24299
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Role of Tyrosine
Phosphorylation in Potassium Channel Activation
FUNCTIONAL ASSOCIATION WITH PROLACTIN RECEPTOR AND JAK2 TYROSINE
KINASE (*)
(Received for publication, May 19, 1995)
Natalia B.
Prevarskaya (§),
,
Roman N.
Skryma
(1),
Pierre
Vacher
(1),
Nathalie
Daniel
(2),
Jean
Djiane
(2),
Bernard
Dufy
(1)From the
(1)Laboratory of Neurophysiology, University
of Bordeaux II, CNRS URA 1200, Bordeaux 33076 and the
(2)Unit of Molecular Endocrinology, INRA, Jouy en
Josas 78352, France
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
Chinese hamster ovary (CHO) cells, stably transfected with the
long form of the prolactin (PRL) receptor (PRL-R) cDNA, were used for
PRL-R signal transduction studies. Patch-clamp technique in whole cell
and cell-free configurations were employed. Exposure of transfected CHO
cells to 5 nM PRL led to the increase of Ca -
and voltage-dependent K channel (K )
activity. The effect was direct as it was observed also in excised
patch experiments. A series of tyrosine kinase inhibitors was studied
to investigate the possible involvement of protein tyrosine kinases in
K functioning and its stimulation by PRL. Genistein,
lavendustin A, and herbimycin A decreased in a concentration and
time-dependent manner the amplitude of the K current in
whole cell and the open probability of K channels in
cell-free experiments. The subsequent application of PRL was
ineffective. The protein tyrosine phosphatase inhibitor orthovanadate
(1 mM) stimulated K channel activity in excised
patches, indicating that channels can be modulated in opposite
directions by protein tyrosine kinase and protein tyrosine phosphatase.
Moreover, in whole cell experiments as well as in excised patch
recordings, anti-JAK2 tyrosine kinase antibody decreased the K conductance and the open probability of the K channels. Subsequent application of PRL was no longer able to
stimulate K conductance. Immunoblotting studies using the
same anti-JAK2 antibody, revealed the constitutive association of JAK2
kinase with PRL-R. Preincubation of anti-JAK2 antibody with the JAK2
Immunizing Peptide abolished the effects observed using anti-JAK2
antibody alone in both electrophysiological and immunoblotting studies. We conclude from these findings that these K channels
are regulated through tyrosine phosphorylation/dephosphorylation; JAK2
tyrosine kinase, constitutively associated with PRL-R, is implicated in
PRL stimulation of K channels.
INTRODUCTION
Prolactin (PRL) ( )is a multifunctional pituitary
hormone involved in the control of a wide variety of physiological
processes in vertebrates, including lactation, reproduction, immune
responses, and osmoregulation, as well as cell
proliferation(1, 2, 3) . The PRL receptor
(PRL-R) belongs to the cytokine-growth factor receptor superfamily that
includes receptors for growth hormone, erythropoietin, numerous
hematopoietic interleukins (IL)-2, IL-3, IL-4, IL-5, IL-6,IL-7, IL-9,
granulocyte colony-stimulating factor, granulomacrophage
colony-stimulating factor, and ciliary neurotrophic
factor(4, 5) . This family of receptors possesses
common structural motifs, both external (two disulfide loops and the
WSXWS homology box) and internal (proline-rich homology box
1). Recent studies have been marked by considerable progress in
understanding the mechanisms of intracellular signaling for the
different members of this family, particularly for PRL-R. Most of the
data were obtained in the PRL-dependent rat T lymphoma cell line Nb2.
It has been shown by several groups that, following binding of PRL to
the PRL-R in these cells, dimerization of the receptor occurs (6, 7) prior to phosphorylation of an associated
tyrosine kinase (JAK2). This represents the first event in the process
of PRL-R signal transduction(8, 9) . Other studies
demonstrated that PRL stimulation of Nb2 cells induced a concentration-
and time-dependent activation of another protein tyrosine kinase,
p59 , from the Src protein tyrosine kinase family (10) . On the other hand, more and more studies demonstrate an
important role of ion channels in receptor signal
transduction(11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22) .
Several different mechanisms have been proposed for channel involvement
in signal transduction: direct agonist effect on the
channel(15, 16) , second messenger participation in
channel modulation(17, 18, 19) , and
regulation by kinases and phosphatases through channel
phosphorylation/dephosphorylation
processes(11, 20, 21, 22) . Moreover
channel regulation by phosphorylation has been shown to play a key role
in physiological processes such as proliferation and transformation (23, 24, 25) . Nothing, however, is known
about the putative role of channel phosphorylation in cytokine-growth
factor receptor superfamily signal transduction and, in particular, in
PRL-R signal transduction. The signal transduction mechanism for the
full-length PRL receptor has been studied using a CHO line stably
transfected with the cDNA of the long form of rabbit mammary
PRL-R(26) . These CHO-transfected cells responded to PRL by
stimulating the cotransfected milk protein gene promoter(27) ,
proving that such cells are fully capable of transmitting the PRL
signal and that PRL-R is functional. In a series of studies using patch
clamp and microfluorimetric techniques, we analyzed the first steps of
the PRL-R signal transduction pathway: an increase in intracellular
Ca (28, 29) and direct stimulation
of calcium- and voltage-activated potassium channels (K )
by PRL(29) . These observations suggested the existence of a
regulatory complex involving a protein kinase tightly associated with
K channels and PRL-R. Furthermore, by immunoblotting
studies we presented evidence for the tyrosine phosphorylation of this
type of PRL-R, the association of JAK2 tyrosine kinase with the
receptor, as well as changes in tyrosine phosphorylation of a number of
cytoplasmic proteins(30) . In this article, we report on the
very first steps in PRL-R signal transduction at the plasma membrane
level: we demonstrate an endogenous large conductance K channel as the primary ionic event triggered by PRL. These
K channels are constitutively regulated through tyrosine
phosphorylation/dephosphorylation. We also show that JAK2 tyrosine
kinase, associated with PRL-R, is implicated in the stimulation of
K channels by PRL.
EXPERIMENTAL PROCEDURES
Cell CulturesWe used CHO cells transfected with
PRL-R-cDNA (CHO E3) as described previously(31) . Different
subclones were challenged for PRL binding, and one of them (E32),
exhibiting the highest binding capacity (12% specific binding versus 4% for E3) was used in these experiments. The PRL
receptor in E32 clone has a K = 10.8
10 M which is
higher than that of the parental E3 clone(32) , but the same
number of sites (about 9000). The cells were grown in Ham's F-12
medium (Seromed, Strasbourg, France) containing 10% (v/v) fetal calf
serum (Life Technologies, Inc.). Medium was changed every 2-3
days. Cells were maintained at 37 °C in a humified atmosphere
gassed with 95% air, 5% CO . In order to avoid occupancy of
PRL receptors by lactogenic factors contained in the serum of the
culture medium, 6-24 h before the experiments cells were
transferred into a serum-free medium(32) . This medium was
derived from the GC3 medium described by Gasser et al.(33) and is a 1:1 mixture of Dulbecco's modified
Eagle's medium and Ham's F-12 (Seromed) supplemented with
nonessential amino acids (Life Technologies, Inc.), insulin (Sigma; 80
milliunits/ml), glutamine (Sigma, 2.5 nM), and transferrin
(Life Technologies, Inc., 10 mg/ml).
Electrophysiological RecordingsThe cultures were
viewed under phase contrast with a ``Leitz-Diavert'' (Leitz,
Germany) inverted microscope. Electrodes were positioned with
``Leitz'' (Germany) micromanipulators. Grounding was through
a silver chloride-coated silver wire inserted into an agar bridge (4%
agar in electrode solution). An Axopatch-1D amplifier (Axon
Instruments, Inc., Foster City, Ca) was used for tight seal, whole
cell, and cell-free voltage clamping. Stimulus control and data
acquisition and processing were carried out with a PC computer AT-80386
(Tandon, Moorpark, CA), fitted with a Labmaster TL-1 interface, using
Pclamp 5.5.1 software (Axon Instruments, Inc., interface and software).
Electrode offset was balanced before forming a ``giga-seal.''
Leakage and capacitive current subtraction protocols were composed of
four or five hyperpolarizing pulses, one-fourth or one-fifth pulse,
respectively, and were applied from a holding potential before test
pulses eliciting active responses. During data analysis, leak data were
subtracted from the raw data. Series resistances were compensated and
were calculated before and after compensation. Recordings where series
resistance resulted in a 5 mV or greater error in voltage commands were
discarded. Currents were low pass-filtered at 2 KHz with an eight-pole
Bessel filter (-3dB) and digitized at 10 KHz for storage and analysis.
Data and Statistical AnalysisPeak currents in
whole cell recordings were measured using the automatic peak detection
function in the Clampan section of the Pclamp software. Late currents
measured isochronally were taken before the end of the pulse to avoid
capacitative transients spread out by digital filtering.Single
channel data analysis was performed after elimination of capacity
transients and leak current by subtraction of record averages without
channel activity from each current record. The openings and closings of
the channel were detected using a criterion of a 50% excursion between
fully open and fully closed states to determine the occurrence of an
opening or closing event such as crossings of the line at a
half-distance between zero current level and a level corresponding to
the average open channel amplitude. In this way, real current records
were put into ideal form by setting all intermediate amplitudes to the
level of zero current line or to the level of the average open channel
amplitude. The open probability (P ) was calculated
as the open time integral divided by the number of channels in the
patch and the duration of the data segment analyzed. The number of
channels was estimated by examining the record for multiple openings
under conditions of high open probability (P >
0.75). Results are expressed as means ± S.D. where
appropriate. Each experiment was repeated several times.
Student's t test was used for statistical comparison
among means and differences with p < 0.05 were considered
significant.
Recording SolutionsFor whole cell studies the
standard extracellular solution contained (in mM): 140 NaCl, 5
KCl, 10 CaCl , 2 MgCl , 0.3
Na HPO , 0.4 KH PO , 4
NaHCO , 5 glucose, 10 HEPES. The osmolality of the external
salt solution was adjusted to 300-310 mosmol/kg with sucrose, and
pH adjusted to 7.3 ± 0.01 with NaOH. In some experiments,
tetrodotoxin (TTX, 1-5 µM) was added to the bathing
solution to prevent activation of the fast sodium current. The
recording pipette was filled with an artificial intracellular saline
containing (in mM): 150 potassium gluconate, 2
MgCl , 1.1 EGTA, 5 HEPES (pH 7.3 ± 0.01 with KOH),
osmolarity 290 mosmol/kg. For the study of single K channels the solutions used in outside-out patch experiments were
(in mM): 140 NaCl, 5 KCl, 10 CaCl , 2
MgCl , 0.3 Na HPO , 0.4
KH PO , 4 NaHCO , 5 glucose, 10 HEPES,
0.003 TTX (pH 7.3) for the bath; and 150 potassium gluconate, 2
MgCl , 1.1 EGTA, 5 HEPES (pH 7.3) for the pipette. The
solutions used in inside-out patch experiments were (in mM):
150 potassium gluconate, 2 MgCl , 5 HEPES, 1.1 EGTA (pH 7.3)
for the bath; 140 NaCl, 5 KCl, 10 CaCl , 2 MgCl ,
0.3 Na HPO , 0.4 KH PO , 4
NaHCO , 5 glucose, 10 HEPES, 0.003 TTX (pH 7.3) for the
pipette. Free Ca concentrations in the range of 10
nM to 1 µM for the solutions, applied from the
inner side of membrane, were buffered with 1.1 mM EGTA and
were calculated using the method previously described by Abercrombie et al.(34) . Calcium concentrations greater than 1
µM were achieved by adding the desired amount of
CaCl . In all studies of K channel activity
0.1 mM Mg-ATP was added to the internal solution. To allow
local drug application to the investigated cell an additional
``pouring'' pipette with a tip opening of 10-30 µm
was used. This pipette was filled with the same extracellular saline as
was in the bath and the drug under investigation added to it in
appropriate concentrations. The pipette was brought close to the
investigated cell at a distance of 50-100 µm. All experiments
were performed at room temperature (20-22 °C).
Western TransferE32 cells were grown to
confluence in 10-cm dishes with Ham's F-12 and 10% fetal calf
serum, and 24 h before addition of hormone, were transferred to GC3
medium. The ovine PRL was added at 500 ng/ml, and incubated for 3 min
at 37 °C. Reaction was stopped by washing E32 cells three times
with cold buffer (10 mM sodium phosphate, 137 mM NaCl, 1 mM Na VO (pH 7. 5)).
Immediately thereafter, cells were scraped in lysis buffer (20 mM Tris, 137 mM NaCl, 2.7 mM KCl, 10% glycerol, 1%
Brij 96, 1 mM phenylmethylsulfonyl fluoride, 1 mM
Na VO , and 5 mg/ml aprotinin plus 2 mg/ml
leupeptin (pH 7.5)) and left 30 min at 4 °C. After centrifugation
at 15,000 rpm for 10 min, prolactin receptor complexes were
immunoprecipitated with anti-JAK2 antibody (Upstate Biotechnology,
Inc., Lake Placid, NY) and harvested with protein G-Sepharose beads.
After extensive washes, immune complexes were eluted by boiling in SDS
sample buffer (0.0625 M Tris-HCl (pH 6.8), 2% SDS, 10%
glycerol, 5% -mercaptoethanol). Samples were loaded onto at 8%
Laemlli SDS gel, and after completion of the run, resolved proteins
were transferred to nitrocellulose (400 mA for 4 h at 0 °C),
blocked with 5% milk powder in 0.1% Tween, PBS and then probed with the
indicated antibodies in blocking buffer for 1 h (S46 or anti-JAK2 at
1/4000), washed, and preincubated with a second horseradish
peroxidase-conjugated anti-species-specific antibodies for 1 h
(anti-goat or anti-rabbit antibody, respectively, at 1/20,000 and
1/15,000). Immune complexes were detected by enhanced chemiluminescence
(ECL).
Membrane Stripping and RehybridizationIn order to
rehybridize the membranes with other antibodies, they were stripped 30
mn at 60 °C in 62.5 mM Tris (pH 6.7), 2% SDS, 100 mM -mercaptoethanol. After extensive washes, the membranes were
then processed as described before.
ChemicalsPRL (o-PRL-19) and anti-rat PRL antibody
were kindly provided by the NIDDK (National Hormone and Pituitary
Program, University of Maryland School of Medicine, Baltimore, MD).
Mg-ATP, TTX, genistein, genistin, and orthovanadate were from Sigma.
Charybdotoxin (CTX) was obtained from Latoxan (Rosans, France).
Lavendustin A and herbimycin A were from Life Technologies, Inc.
Antibody anti-JAK2 and JAK2 immunizing peptide were purchased from
Upstate Biotechnology, Inc. Normal rabbit serum was from Sera Lab
(London, United Kingdom).
RESULTS
As was demonstrated by our previous studies(35) , a
210-picosiemens K conductance, dependent on voltage
and intracellular Ca , was revealed by patch-clamp
experiments in CHO cells. To check whether the K channels
could be phosphorylated, we studied the effect of ATP, which serves as
a substrate for protein kinase, on the activity of the K channels in CHO cells. Experiments using Mg-ATP (10-100
µM), applied to the cytoplasmic side of the membrane,
showed an increase in the open probability of the channel, proving that
a protein kinase is tightly associated with it. Fig. 1shows the
very low K channel open probability values in the absence
of ATP in the internal solution and the much higher values in the
presence of ATP. The open probability values in the absence of ATP were
so low that it was impossible to carry out the statistical analysis
required to establish the effect of PRL on K channel
activity under these conditions. In whole cell experiments without ATP
in the patch pipette, no effect of PRL on K total
current was observed. ATP hydrolysis was required for channel
modulation, because the nonhydrolyzable ATP analog, AMPPNP, was
ineffective (not shown). As, on the one hand, tyrosine kinase was found
to be a primary target of PRL in PRL-R signal transduction(8, 9) and, on the other hand, the K channels
stimulated by PRL were found to be associated with protein kinase, we
assumed the existence of a PRL-R-K channel-tyrosine kinase
regulatory complex. To investigate whether the K channels stimulated by PRL may be modulated by an endogenous
tyrosine kinase, we examined the effects of different tyrosine kinase
inhibitors on K channel activity, using both whole cell
and cell-free modes of the patch-clamp technique. In these studies we
used two types of experiments differing in the duration of drug
application
Figure 1:
The time course of the activity of the
Ca -activated K channel obtained from
excised (outside-out) patch recordings in the absence ( ) or
presence ( ) of 100 µM ATP in the patch pipette at a
membrane potential of +10 mV and 0.2 µM internal-free
Ca . Representative experiments for such experimental
conditions are shown.
Short Application of the Drug for Periods Varying from 15 s to
Several MinutesApplication was performed from an additional
pipette directly on the cell membrane (in whole cell patch-clamp
configuration) or pieces excised from the membrane, containing one or
more ion channels (excised-patch configuration).Bath application (3
min) of the protein tyrosine kinase inhibitor genistein (36, 37) caused a progressive reduction in the
K current (Fig. 2A). Further
application of PRL was ineffective. Genistein concentrations lower than
50 µM were ineffective under these experimental conditions (n = 6). After genistein was washed out, K currents gradually recovered, indicating that the depression was
reversible. Genistin, an analog of genistein that lacks protein
tyrosine kinase inhibitory activity(36) , had no effect on
K current (n = 4; Fig. 9A). We also tested two structurally distinct
protein tyrosine kinase inhibitors: herbimycin A (9, 38) and lavendustin A(36, 39) .
Herbimycin A (1.5 µM) and lavendustin A (10
µM) depressed K currents to 57 ± 8% (n = 8) and to 54 ± 5% (n = 6)
of control, respectively. Fig. 2B shows an example of
K current inhibition induced by 3-min application of 10
µM lavendustin A and current-voltage relationships for
this effect, where current amplitudes were plotted at different test
potentials. K currents were evoked by 160-ms test pulses
from a holding potential of -40 to +10 mV.
Figure 2:
The effects of tyrosine kinase inhibitors
on K current in CHO-E32 cells. A illustrates
an example of the effect of 50 µM genistein on
K current recorded before genistein application
( ), 8 min after the application ( ), and after washout
( ). The membrane was depolarized from V = -40 to +20 mV at 160-ms intervals. B illustrates an example of the effect of 10 µM of
lavendustin A on K current recorded using a similar
protocol to the experiment in A. For both inhibitors the
original current traces are presented in the top panels and
current-voltage (I-V) relationships in the lower panels.
Calibration: 30 ms, 100 pA. C illustrates the effects of 6-h
treatment of CHO E32 cells with varying concentrations of protein
kinase inhibitors ( , genistein; , lavendustin A, ,
herbimycin A) on normalized peak K currents. Results
shown (mean ± S.E.) are representative of at least three
separate, independent experiments.
Figure 9:
Summary histograms of K
channel modulation in CHO-E32 cells. A illustrates the
histogram showing the effects of the various drugs studied on
normalized peak currents obtained by whole cell experiments. B illustrates the histogram showing the effects of these drugs on
the ratio of the channel open probability (P )
obtained by single channel recordings.
Preincubation of All Cells by Addition of the Drug to the
Bath Solution for a Time Varying from 30 min to Several
HoursThe concentration dependence of current depression caused
by three tyrosine kinase inhibitors is shown in Fig. 2C for cells preincubated with the drugs for 6 h. Under these
conditions, even when cells were pretreated with low concentrations of
inhibitors (n = 5 for cells treated with 10
µM of genistein, n = 4 for 100 nM of herbimycin, and n = 5 for 1 µM of
lavendustin), the application of 5 nM PRL on these cells was
ineffective (data not shown).Cell-free experiments demonstrated
that the effects of PRL and protein tyrosine kinase inhibitors were not
mediated by intracellular processes, as they could be also observed in
detached patches. Fig. 3shows K channel
activity stimulation by PRL and its inhibition by genistein (n = 7/9 patches). PRL (5 nM) caused an increase in
the open probability of the channels (Fig. 3B),
displaying the half-maximum increase in the open probability within 3.6
± 1.3 min. The open probability of the channel after the
addition of PRL was not constant, but oscillated between lower and
higher open probability values (Fig. 3B). Subsequent
addition of 100 µM genistein inhibited this K channel activity almost completely within 7 ± 2 min (Fig. 3B). The amplitude histograms (Fig. 3C) for K channels in control
(mean = 8.48 ± 0.12 pA) and in the presence of PRL (mean
= 8.34 ± 0.18 pA) demonstrate that PRL does not activate
additional conductances. Moreover, prolactin did not stimulate
K channel activity in the presence of 30 nM CTX, a K channel inhibitor in CHO cells(20) ,
indicating that PRL activated the CTX-sensitive K channels
and no other type of outward channels (not shown). As in whole cell
experiments, genistin was ineffective (Fig. 9B).
Application of 1.5 µM herbimycin A also decreased channel
open probability without affecting single-channel conductance (n = 4/5 patches, Fig. 4). The subsequent addition of
PRL was ineffective.
Figure 3:
Modulation of K single
channel activity by PRL and its inhibition by genistein. A illustrates representative recordings of single K currents in a cell-free patch in the outside-out configuration.
K channel activity in this patch was obtained with 0.1
µM internal-free Ca at a membrane
potential of +40 mV. Recordings are shown for the control
solution, 6 min after application of 5 nM PRL, and 2 and 8 min
after the subsequent application of 100 µM of genistein,
respectively. The time course of the open probability of the K channels in the control and in the presence of PRL and genistein
is demonstrated in B. C illustrates the amplitude
histograms for single K channel conductance for
control and in the presence of 5 nM PRL.
Figure 4:
The effect of herbimycin A on K channel activity. Representative records of single K currents in excised (outside-out) membrane patch (top).
K channel activity in this patch was obtained with 0.5
µM internal-free Ca at a membrane
potential of +20 mV. Records are shown for the control solution,
10 min after 1.5 µM herbimycin application and 3 min after
the subsequent addition of 5 nM PRL. The open probability of
the K channel versus time is presented in the
lower panel.
As protein tyrosine kinase inhibitors in high
concentrations are known to be able to inhibit not only protein
tyrosine kinase but also protein kinase C and protein kinase A kinases
in some cell types(36) , we checked the putative involvement of
protein kinase C and protein kinase A in the mechanisms studied. We
tested both activators and inhibitors of protein kinase C and protein
kinase A (10-8 M phorbol 12-myristate 13-acetate
application, as protein kinase C activator; 10-6 M phorbol 12-myristate 13-acetate 24-h incubation, as protein kinase
C inhibitor; 250 µM phloretin, as protein kinase C
inhibitor; 2 µM forskolin and 1 mM 8-bromo-cAMP,
as protein kinase A activators) on K channel activity
and on the stimulated effect of PRL. None of these drugs had any
effect. A protein kinase C biochemical assay (40) was also
carried out. 50-100 µM genistein had no effect in
these studies. The possibility that these channels may be regulated
by protein tyrosine phosphatase as well as by protein tyrosine kinase
was investigated by application of the protein tyrosine phosphatase
inhibitor, sodium orthovanadate(41) , to the cytoplasmic side
of the cell-free patch. Orthovanadate (1 mM) increased the
open probability of the channels in a time-dependent manner (Fig. 5). On average, activity increased by 198 ± 27%
within 5 min (n = 6/9 patches). Fig. 5B shows the duration histograms for the channel prior to application
of orthovanadate, then 2 and 8 min afterwards, respectively. In the
presence of orthovanadate, channel openings were longer, as indicated
by an increase in the relative number of events and the time constant
to for the open state.
Figure 5:
The effect of orthovanadate on K channel activity. A illustrates representative records
of single K currents in excised (inside-out) membrane
patches. K channel activity in this patch was obtained
with 0.2 µM internal-free Ca at a
membrane potential of +40 mV. Records are shown for the control
solution, and 2 and 8 min after 1 mM orthovanadate
application, respectively. B illustrates the corresponding
open time distributions with single exponential fit. Time constants: t = 1.9 ms (n = 604) for control, t = 2.3 ms (n = 668) after 2 min, and t = 6.8 ms (n = 1023) after 8 min of
orthovanadate addition, respectively.
The preceding results strongly support the
conclusion that the functioning of PRL-stimulated K channels is modulated by protein tyrosine kinases and protein
tyrosine phosphatases and thus regulated by constitutive tyrosine
phosphorylation/dephosphorylation. It has already been shown that
tyrosine-phosphorylated PRL-R is associated with JAK2
kinase(30) . Additional immunoblotting experiments were carried
out to find out if this association was constitutive. Solubilized
proteins from E32 cells incubated with or without 500 ng/ml of
prolactin were immunoprecipitated with anti-PRL-R antibody 46 and
analyzed for the presence of JAK2 in the complex. As shown in Fig. 6A, a protein of 130 kDa was detected in the blot
hybridized with anti-JAK2, corresponding to JAK2 kinase. This protein
was revealed in the presence or absence of stimulation by ovine PRL,
showing that this protein is constitutively associated with the PRL
receptor. A rehybridization of the same blot with S46 shows the
presence of the same amount of receptor in each line. In Fig. 6B, we demonstrate the specificity of the
recognition of JAK2 by the antibody. Cell extracts were
immunoprecipitated with anti-JAK2 antibody or anti-PRL-R antibody and
subjected to SDS-PAGE and Western blotting. Each blot was incubated
either with anti-JAK2 antibody or with anti-JAK2 antibody preincubated
with a peptide corresponding to the amino acid residues 758-776
of murine JAK2 (JAK2 immunizing peptide). In JAK2 immunoprecipitates we
observed that a protein of 130 kDa was specifically displaced by the
presence of the peptide. Nonspecific bands were always present
following incubation in the presence of the peptide. The same finding
was observed in 46 immunoprecipitates. The 130-kDa band was not
revealed in the presence of the peptide. Therefore, the 130-kDa protein
revealed on the blot is the tyrosine kinase JAK2, and this kinase is
constitutively associated with the prolactin receptor. To investigate
whether K channels are also constitutively associated with
JAK2 kinase we studied the effect of the anti-JAK2 kinase antibody on
the of the K channel activity. Anti-JAK2 antibody (diluted
1:1000 from the indicated antibody) was introduced into the internal
solution of the patch pipette. In whole cell experiments, the amplitude
of the K current gradually decreased following rupture of
the seal. In control conditions of whole cell experiments, the K current was stable under internal perfusion. No decrease in
current (or ``run-down'') was observed during recordings
lasting 20 min or more. Fig. 7shows the time dependence of the
decrease in K current caused by anti-JAK2 antibody. Within
approximately 10 min the current was almost completely inhibited (n = 5). Subsequent application of PRL was ineffective (Fig. 7). Anti-JAK2 antibody applied to the cytoplasmic side of
the membrane in inside-out studies decreased the open probability of
the channel to 73 ± 18% (n = 4/4 patches) of
control (Fig. 8). Subsequent application of PRL did not
stimulate channel activity (Fig. 8). When anti-JAK2 antibody was
preincubated with a peptide corresponding to the amino acid residues
758-776 of murine JAK2 (JAK2 immunizing peptide) and this mixture
applied to the cytoplasmic side of the membrane, the decrease in
K current in the whole cell experiments (Fig. 7) and in the open probability of the channel in
inside-out experiments (Fig. 8) were not observed. As the
anti-JAK2 antibody was obtained from Upstate Biotechnology, Inc. in
rabbit serum, we checked the effect of non-immune rabbit serum on
K conductance as a control. Rabbit serum at the same
dilution (1:1000) was ineffective in both whole cell and inside-out
experiments (not shown). An immune serum antibody (anti-rat PRL
antibody) was used as an additional control. At the same dilution it
was also ineffective.
Figure 6:
Association of JAK2 with the prolactin
receptor in CHO cells. A illustrates JAK2 constitutive
association with the PRL receptor. E32 cells were left untreated or
treated with PRL (500 ng/ml), solubilized, and immunoprecipitated with
prolactin receptor antiserum 46. All samples were analyzed by SDS-PAGE
under reducing conditions, followed by immunoblotting with anti-PRL-R
antibody 46 or anti-JAK2 antibody (Upstate Biotechnology, Inc.).
Molecular weight standards are indicated on the left. B illustrates the blockage of anti-JAK2 reactivity with JAK2
peptide. E32 cell lysates were immunoprecipitated with anti-JAK2
antibody or anti-PRL-R antibody 46 and the immunoprecipitates were
processed for Western blotting. Blots were probed with anti-JAK2
antibody or with anti-JAK2 antibody + peptide (corresponding to
the amino acid acid residues 758-776 of murine
JAK2).
Figure 7:
Time
course of the inhibition of the K current by anti-JAK2
antibody. Top, current traces obtained after seal rupture in
the presence of anti-JAK2 antibody in the patch pipette. Currents were
evoked by 160-ms test pulses from holding potential of -60 mV to
+50 mV test potential. Lower panel, the respective plot
of normalized current (I/I ) with
anti-JAK2 antibody or with anti-JAK2 antibody+ peptide versus time.
Figure 8:
Effect of anti-JAK2 antibody on K channel activity. Representative records of single K currents from excised (inside-out) membrane patch (top).
K channel activity in this patch was obtained with 0.2
µM internal-free Ca at a membrane
potential of +50 mV. Records are shown for control solution, 2 min
after anti-JAK2-antibody application, following the subsequent addition
of PRL and during recovery. The open probability of the K channel versus time is presented in the lower
panel.
Fig. 9presents a summary of the
effects of all the drugs studied on normalized peak currents, obtained
by whole cell experiments (Fig. 9A) and normalized P , obtained by excised patch experiments (Fig. 9B).
DISCUSSION
We conclude from these findings that the activation of
K channels by PRL in CHO cells, transfected with cDNA of
the long form of PRL-R, is the primary ionic event in PRL-R signal
transduction. K channels are constitutively regulated
through tyrosine phosphorylation/dephosphorylation. Stimulation of the
channels by PRL possibly occurs through phosphorylation of protein
tyrosine residues of the channel or of one or more associated proteins.
The observation that K channel stimulation by PRL does not
occur in the presence of anti-JAK2 kinase antibody suggests that at
least one of the kinases involved in the channel stimulation by PRL may
be JAK2 tyrosine kinase. Although the association of PRL-R with
JAK2(8, 9, 30) , JAK1(42) , or Fyn (10) tyrosine kinases has already been clearly demonstrated,
the cascade of ionic events induced by PRL and the nature of ion
channels involved has not yet been studied. Our earlier studies have
characterized a membrane hyperpolarization, caused by K channel stimulation, and Ca influx among the
first detectable responses to PRL-R activation(29) . The
underlying mechanisms are, however, not very clearly understood. In the
present study, we applied the patch-clamp recording technique in order
to unravel the mechanism of K channel activation by PRL
and to identify the nature of the associated protein kinase. In our
experiments ATP (10-100 µM) increased the open
probability of the K channel, therefore showing that a
protein kinase is involved in the regulation of channel activity.
Moreover PRL was unable to stimulate this activity when ATP was absent
from the internal solution, demonstrating that kinase phosphorylation
is needed for channel stimulation by PRL. Thus, we concluded that
protein kinase is closely associated with K channel and
PRL-R in a regulatory complex. It was recently demonstrated that in
murine fibroblast cell lines, transfected with Ras or Raf plasmids, the
K , CTX-sensitive channel is up-regulated by oncogenic
p21 and that this regulation appears to be due to raf kinase-dependent induction of channel expression(43) . The
application of either epidermal growth factor or platelet-derived
growth factor to nontransfected cells caused a time-dependent induction
of K channels, obviously, through activation of endogenous
cellular p21 . Epidermal growth factor induction of the
K channel was blocked by the tyrosine kinase inhibitors
lavendustin A (1 µM) or genistein (50 µM).
However, application of genistein to cells transfected by oncogenic ras had no effect on K current density,
indicating that genistein had no direct inhibitory effect on the
K channel. These results suggest that ras regulates the K channels through serine/threonine
kinase and not through protein tyrosine kinase. Our experiments using
tyrosine kinase inhibitors show a distinct mechanism of K channel regulation in CHO cells transfected with cDNA of the long
form of PRL-R: the direct regulation of K channels by
tyrosine kinase (as this activity was inhibited directly in whole cell
and single channel experiments by three distinct tyrosine kinase
inhibitors) and modulation of this activity by PRL (as PRL was no
longer able to stimulate K channel activity when the cells
were treated with protein tyrosine kinase inhibitors). Experiments
using protein kinase C and protein kinase A activators and inhibitors
showed that these kinases are not involved in the channel regulation
mechanisms. For epidermal growth factor receptor, which has
intrinsic tyrosine kinase(44) , the first event is activation
of voltage-independent Ca channels defined as direct
receptor-operated channels (12) . This in turn causes the
activation of Ca -dependent K channels, sensitive to charybdotoxin(12, 13) ,
resulting in delayed membrane hyperpolarization and leading to the
activation of a second class of hyperpolarization-sensitive
Ca channels(14) . We did not observe the
Ca conductance activation prior to K channel stimulation(29) . Conversely, our results
demonstrate that the first ionic event in PRL-R signal transduction is
K channel activation, since this activation is observed in
excised patches. Based on the observed inhibitory effects of protein
tyrosine kinase inhibitors on the activity of PRL-stimulated K channels, we propose that tyrosine kinase is involved in the
positive regulation of these channels. The direct tyrosine
phosphorylation of the delayed rectifier K channel has
also been proposed for the m1 muscarinic acetylcholine
receptor(11) . This tyrosine kinase regulation is obviously an
essential link in PRL signal transduction as it was recently found that
the tyrosine kinase inhibitor herbimycin A was able to block a
substantial portion of the prolactin signal to the milk protein gene
promoter, -lactoglobulin (30) . In Nb2 cells it was shown
that herbimycin A could also abolish the JAK2 kinase and receptor
phosphorylation(9) . In our study the effects of PRL and
protein tyrosine kinase inhibitors were observed in excised-patch
experiments, indicating that the effects are not controlled by cellular
metabolism, but are direct and that protein tyrosine kinase remains
closely associated with K channel activity. In this
context it was of interest to check the effect of anti-JAK2 antibody on
K channel activity. The effectiveness of using antibodies
in patch-clamp experiments was previously shown by Schweizer et
al.(45) . When anti-JAK2 antibody was introduced into the
patch pipette in whole cell experiments, the K conductance
was almost completely inhibited within an average of 15 min, and PRL
was no longer able to stimulate K conductance. Anti-JAK2
antibody also decreased the open probability of K channels
when it was applied to the cytoplasmic side of the membrane in the
inside-out patch mode. In immunoblotting experiments JAK2 kinase was
revealed in the presence or absence of stimulation by PRL, showing that
it is constitutively associated with the PRL-R. On the other hand,
electrophysiological studies using anti-JAK2 antibody showed that this
kinase is also constitutively associated with the K channel. The results with JAK2 immunizing peptide, demonstrating
the suppression of the effects observed using anti-JAK2 antibody alone
in both electrophysiological and immunoblotting studies, show that the
effects of the anti-JAK2 antibody are specific. The ability of the
constitutively active kinases to stimulate cellular responses has
previously been shown for MAP and phosphatidylinositol
3-kinase(46) . On the other hand, there is growing evidence for
the existence of a protein tyrosine kinase activation mechanism that
functions indirectly by second messengers. For example, in the brain,
membrane depolarization, which causes an increase in intracellular
Ca levels, increases protein tyrosine kinase (47) and protein mitogen-activated protein kinase (48) activity. Extracellular signals (in our case PRL) appear
to stimulate the activity of protein tyrosine kinase, but it may also
be regulated by other factors (e.g. membrane potential and
intracellular Ca ). This constitutive activity of JAK2
kinase is the reason for K channel inhibition by the
anti-JAK2 antibody in the absence of PRL stimulation. Therefore, our
results demonstrate the functional involvement of JAK2 kinase in
constitutive K channel activity and the stimulation of
these channels by PRL. However, it was shown by immunoblotting
experiments that genistein (100-500 µM) was not able
to inhibit the JAK2 kinase phosphorylation induced by growth hormone
but it blocked the tyrosyl phosphorylation of other proteins
(intermediary tyrosine kinases)(49, 50) . This fact
may be explained by the various examples of interactions at the level
of the same protein; many phosphoproteins are phosphorylated at the
same or at distinct residues by more than one protein kinase: in the
case of tyrosine hydroxylase, the nicotinic acetylcholine receptor,
synapsin 1, or Ca channel of the L type(47) .
This multisite protein phosphorylation appears to be the rule rather
than the exception(47) . Therefore, we cannot completely
exclude the possible involvement of other tyrosine kinases in K channel functions. The fact that the channel was activated by
the protein tyrosine phosphatase inhibitor orthovanadate in excised
patches suggests that the channel can be modulated in opposite
directions by protein tyrosine kinase and protein tyrosine phosphatase.
This modulation may be due to phosphorylation/dephosphorylation of the
channels themselves or of regulatory protein(s) associated with these
channels and the PRL receptor. The protein tyrosine phosphatase
endogenous to CHO cells was observed in most excised patches and thus
may be a member of the transmembrane class of protein tyrosine
phosphatase (51, 52) or of the cytoplasmic protein
tyrosine phosphatase which possess an SH2 domain or another means of
association with membrane-bound proteins(53, 54) .
These studies suggest that tyrosine phosphorylation/dephosphorylation
systems can modify K channels rapidly, producing flexible
changes in PRL-R signaling. Similar types of complexes that contain
regulatory protein kinases and phosphatases have previously been shown
for a variety of different ion channels(20, 21, 22, 55, 56, 57) and
for K channels in
particular(20, 21, 56, 57) . But the
participation of such protein tyrosine kinase modulation of
K channels in PRL signal transduction has never been
shown. To our knowledge this study provides the first example of the
regulation of K channels by PRL and protein tyrosine
kinase in cell-free preparations. Our study is in accordance with a
hypothesis previously proposed (57) about such submembrane
complexing of ion channel proteins with modulatory enzymes like kinases
and phosphatases as a common means by which cells achieve highly
localized regulation of ion channel function by otherwise ubiquitous
biochemical processes. Of particular interest is the finding that the
modulation described here is due to a constitutive JAK2 tyrosine kinase
activity. These results take on added significance because the PRL
receptors were expressed in a heterologous system. However, remarkably,
the endogenous JAK2 tyrosine kinase and endogenous K channels in the host cell associate closely with heterologously
expressed PRL-R and this complex retains its ability to be stimulated
by PRL in a detached membrane patch. As, on the one hand, PRL is
known to stimulate the process of proliferation (58, 59, 60, 61) and, on the other
hand, K channels have also been shown to be involved in
the control of cell
proliferation(25, 43, 62) , the mechanism of
PRL stimulation of K channels through tyrosine
phosphorylation, presented in this work, could provide a clue to
understanding the regulation of cell proliferation by PRL.
FOOTNOTES
- *
- This work was supported by grants from INSERM(N
930704), Association pour la Recherche sur le Cancer (ARC, France) and
Association pour la Recherche sur les Tumeurs de la Prostate (ARTP,
France). The costs of publication of this article were defrayed in part
by the payment of page charges. This article must therefore by hereby
marked ``advertisement'' in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
- §
- To whom all correspondence should be addressed:
Laboratoire de Neurophysiologie, CNRS URA 1200,
Université de Bordeaux II, 146 rue
Léo Saignat, 33076 Bordeaux Cedex, France. Tel.:
33-57-57-15-51; Fax: 33-56-90-14-21.
- (
) - The
abbreviations used are: PRL, prolactin; PRL-R, prolactin receptor; IL,
interleukin; CHO, Chinese hamster ovary; TTX, tetrodotoxin; CTX,
charybdotoxin; AMPPNP, 5`-adenylyl-
, -imidodiphosphate.
ACKNOWLEDGEMENTS
We are grateful to M. F. Odessa for help with the cell
cultures. We also thank G. Gaurier and D. Varoqueaux for excellent
technical assistance.
REFERENCES
- Nicoll, C. S. (1980) Fed. Proc. 39,2563-2566
[Medline]
[Order article via Infotrieve]
- Russel, D. H. (1989) Trends Pharmacol. Sci. 10,40-44
[CrossRef][Medline]
[Order article via Infotrieve]
- Kelly, P. A., Djiane, J., Postel-Vinay, M. C., and Edery, M. (1991) Endocr. Rev. 12,235-251
[Abstract/Free Full Text]
- Bazan, J. F. (1990) Proc. Natl. Acad. Sci. U. S. A. 87,6934-6938
[Abstract/Free Full Text]
- Cosman, D. (1993) Cytokine 5,95-106
[CrossRef][Medline]
[Order article via Infotrieve]
- Djiane, J., Dusanter-Fourt, I., Katoh, M., and Kelly, P. A. (1985) J. Biol. Chem. 260,11430-11435
[Abstract/Free Full Text]
- Fuh, G., Colosi, P., Wood, W. I., and Wells, J. A. (1993) J. Biol. Chem. 268,5376-5381
[Abstract/Free Full Text]
- Rui, M., Kirken, R. A., and Farrar, W. L. (1994) J. Biol. Chem. 269,5364-5368
[Abstract/Free Full Text]
- Lebrun, J. J., Ali, S., Sofer, L., Ullrich, A., and Kelly, P. (1994) J. Biol. Chem. 269,14021-14026
[Abstract/Free Full Text]
- Clevenger, C. V., and Medaglia, M. V. (1994) Mol. Endocrinol. 8,674-681
[Abstract/Free Full Text]
- Huang, X.-Y., Morielli, A. D., and Peralta, E. G. (1993) Cell 75,1145-1156
[CrossRef][Medline]
[Order article via Infotrieve]
- Peppelenbosch, M. P., Tertoolen, L. G. J., and De Laat, S. W. (1991) J. Biol. Chem. 266,19938-19944
[Abstract/Free Full Text]
- Magni, M., Meldolesi, J., and Pandiella, A. (1991) J. Biol. Chem. 266,6329-6335
[Abstract/Free Full Text]
- Peppelenbosch, M. P., Tertoolen, L. G. J., Hertog, J., and De Laat, S. W. (1992) Cell 162,295-303
- Matsunaga, H., Ling, B. N., and Eaton, D. C. (1994) Am. J. Physiol. 267,C456-C465
- Bormann, J. (1988) TrendsNeurosci. 11,112-116
- Penner, R., Matthews, G., and Neher, E. (1988) Nature 334,499-504
[CrossRef][Medline]
[Order article via Infotrieve]
- Graier, W. F., Kukovetz, W. R., and Groschner, K. (1993) Biochem. J. 291,263-267
- Ono, K., Tsujimoto, G., Sakamoto, A., Eto, K., Masaki, T., Ozaki, Y., and Satako, M. (1994) Nature 370,294-297
- White, R. E., Schonbrunn, A., and Armstrong, D. L. (1991) Nature 351,570-573
[CrossRef][Medline]
[Order article via Infotrieve]
- White, R. E., Lee, A. B., Shcherbatko, A. D., Lincoln, T. M., Schonbrunn, A., and Armstrong, D. L. (1993) Nature 361,263-266
[CrossRef][Medline]
[Order article via Infotrieve]
- Wilson, G. F., and Kaczmarek, L. K. (1993) Nature 366,433-438
[CrossRef][Medline]
[Order article via Infotrieve]
- Collin, C., Papagorge, A. G., Lowy, D. R., and Alkon, D. L. (1990) Science 250,1743-1745
[Abstract/Free Full Text]
- Repp, H., Draheim, J., Ruland, J., Seidel, G., Beise, J., Preser, P., and Dreyer, F. (1993) Proc. Natl. Acad. Sci. U. S. A. 90,3703-3707
- Nilius, B., and Wohlrab, W. (1992) J. Physiol. (Lond.) 445,3537-3548
- Edery, M., Jolicoeur, C., Levi, M. C., Dusanter-Fourt, I., Petridou, B., Boutin, J., Lesueur, L., Kelly, P., and Djiane, J. (1989) Proc. Natl. Acad. Sci. U. S. A. 86,2112-2116
[Abstract/Free Full Text]
- Bignon, C., Daniel, N., and Djiane, J. (1993) BioTechniques 15,243-245
[Medline]
[Order article via Infotrieve]
- Vacher, P., Tran Van Chuoi, M., Paly, J., Djiane, J., and Dufy, B. (1994) Endocrinology 134,1213-1218
[Abstract/Free Full Text]
- Prevarskaya, N., Skryma, R., Vacher, P., Daniel, N., Bignon, C., Djiane, J., and Dufy, B. (1994) Am. J. Physiol. 267,C554-C562
- Waters, M. J., Daniel, N., Bignon, C., and Djiane, J. (1995) J. Biol. Chem. 270,5136-5143
[Abstract/Free Full Text]
- Lesueur, L., Edery, M., Paly, J., Clark, J., Kelly, P., and Djiane, J. (1990) Mol. Cell. Endocrinol. 71,7-12
- Lesueur, L., Edery, M., Ali, S., Paly, J., Kelly, P., and Djiane, J. (1991) Proc. Natl. Acad. Sci. U. S. A. 88,824-828
[Abstract/Free Full Text]
- Gasser, F., Mulsant, P., and Gillois, M. (1985) InVitro Cell. & Dev. Biol. 21,588-592
- Abercrombie, R. F., Mazukawa, L. H., Sjodin, A., and Livengood, D. (1981) J. Gen. Physiol. 78,413-428
[Abstract/Free Full Text]
- Skryma, R., Prevarskaya, N., Vacher, P., and Dufy, B. (1994) Am. J. Physiol. 267,C544-C553
- O'Dell, T. J., Kandel, E. R., and Grant, S. G. (1991) Nature 353,558-560
[CrossRef][Medline]
[Order article via Infotrieve]
- Akijama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y. (1987) J. Biol. Chem. 262,5592-5595
[Abstract/Free Full Text]
- Obinata, A. (1991) Exp. Cell. Res. 193,36-39
[CrossRef][Medline]
[Order article via Infotrieve]
- Onoda, T. (1989) J. Nat. Prod. (Lloydia) 52,1252-11257
[CrossRef][Medline]
[Order article via Infotrieve]
- Parant, M. R., and Vial, J. (1990) Anal. Biochem. 184,283-290
[CrossRef][Medline]
[Order article via Infotrieve]
- Swarup, G., Cohen, S., and Garbers, D. L. (1982) Biochem. Biophys. Res. Commun. 107,1104-1109
[CrossRef][Medline]
[Order article via Infotrieve]
- Dusanter-Fourt, I., Muller, O., Ziemiecki, A., Mayeux, P., Drucker, B., Djiane, J., Wilks, A., Harpur, A. G., Fischer, S., and Gisselbrecht, S. (1994) EMBO J. 13,2583-2591
[Medline]
[Order article via Infotrieve]
- Huang, Y., and Rane, S. G. (1994) J. Biol. Chem. 269,31183-31189
[Abstract/Free Full Text]
- Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., Downward, J., Mayes, E. L. V., Whittle, N., Waterfield, M. D., and Seeburg, P. H. (1984) Nature 309,418-425
[CrossRef][Medline]
[Order article via Infotrieve]
- Schweizer, F. E., Schafer, T., Tapparelli, C., Grob, M., Karli, U. O., Heumann, R., Thoenen, H., Bookman, R. J., and Burger, M. M. (1989) Nature 339,709-712
[CrossRef][Medline]
[Order article via Infotrieve]
- Hu, Q., Klippel, A., Muslin, A. J., Fantl, W. J., and Williams, L. T. (1995) Science 268,100-102
[Abstract/Free Full Text]
- Nester, E. J., and Greengard, P. (1993) in Basic Neurochemistry (Siegel, G. J., Agraneff, B. W., Albers, R. W., and Molinoff, P. B., eds) Vol. 22, pp. 449-474, Raven Press Ltd., New York _
- Rosen, L. B., Ginty, D. D., Weber, M. J., and Grenberg, M. E. (1994) Neuron 12,1207-1221
[CrossRef][Medline]
[Order article via Infotrieve]
- VanderKuur, J. A., Wang, X., Zhang, L., Campbell, G. S., Allevato, G., Billestrup, N., Norstedt, G., and Carter-Su, C. (1994) J. Biol. Chem. 34,21709-21717
- Campbell, G. S., Christian, L. J., and Carter-Su, C. (1993) J. Biol. Chem. 268,7427-7434
[Abstract/Free Full Text]
- Charbonneau, H., Tonks, N. K., Walsh, K. A., and Fischer, E. H. (1988) Proc. Natl. Acad. Sci. U. S. A. 85,7182-7186
[Abstract/Free Full Text]
- Alexander, D. R. (1990) New Biol. 2,1049-1062
[Medline]
[Order article via Infotrieve]
- Shen, S. H., Bastien, L., Posner, B. I., and Chretien, P. (1990) Nature 352,736-739
- Yang, O., and Tonks, N. K. (1991) Proc. Natl. Acad. Sci. U. S. A. 88,5949-5953
[Abstract/Free Full Text]
- Wang, Y. T., and Salter, M. W. (1994) Nature 369,233-235
[CrossRef][Medline]
[Order article via Infotrieve]
- Chung, S., Reinhart, P., Martin, B. L., Brantigan, D., and Levitan, J. (1991) Science 253,560-562
[Abstract/Free Full Text]
- Esquerra, M., Wang, J., Foster, C. D., Adelman, J. P., North, R. A., and Levitan, J. B. (1994) Nature 369,563-565
[CrossRef][Medline]
[Order article via Infotrieve]
- Syms, A. J., Harper, M. E., and Griffiths, K. (1985) Prostate 6,145-153
[Medline]
[Order article via Infotrieve]
- Romero, L., Munoz, C., Lopez, A., and Vilches, J. (1993) Prostate 22,1-10
[Medline]
[Order article via Infotrieve]
- Rui, H., Lebrun, J. J., Kirken, R. A., Kelly, P. A., and Farrar, W. L. (1994) Endocrinology 135,1299-1306
[Abstract]
- Wang, Y. F, and Walker, A. M. (1993) Endocrinology 133,2156-2160
[Abstract/Free Full Text]
- Price, M., Lee, S. C., and Deutsch, C. (1989) Proc. Natl. Acad. Sci. U. S. A. 86,10171-10175
[Abstract/Free Full Text]
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. R. Grattan, C. L. Jasoni, X. Liu, G. M. Anderson, and A. E. Herbison
Prolactin Regulation of Gonadotropin-Releasing Hormone Neurons to Suppress Luteinizing Hormone Secretion in Mice
Endocrinology,
September 1, 2007;
148(9):
4344 - 4351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Zhang, Q. Zhang, A. Tengholm, and A. Sjoholm
Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca2+ and insulin secretion
Am J Physiol Cell Physiol,
September 1, 2006;
291(3):
C466 - C475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Kokay, P. M. Bull, R. L. Davis, M. Ludwig, and D. R. Grattan
Expression of the long form of the prolactin receptor in magnocellular oxytocin neurons is associated with specific prolactin regulation of oxytocin neurons
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2006;
290(5):
R1216 - R1225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zhou, L. Liu, and D. Hu
Involvement of BKCa {alpha} subunit tyrosine phosphorylation in vascular hyporesponsiveness of superior mesenteric artery following hemorrhagic shock in rats
Cardiovasc Res,
November 1, 2005;
68(2):
327 - 335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kawasaki, G. E. Davis, and M. J. Davis
Regulation of Ca2+-dependent K+ Current by {alpha}v{beta}3 Integrin Engagement in Vascular Endothelium
J. Biol. Chem.,
March 26, 2004;
279(13):
12959 - 12966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ducret, A.-M. Vacher, and P. Vacher
Effects of Prolactin on Ionic Membrane Conductances in the Human Malignant Astrocytoma Cell Line U87-MG
J Neurophysiol,
March 1, 2004;
91(3):
1203 - 1216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Alioua, A. Mahajan, K. Nishimaru, M. M. Zarei, E. Stefani, and L. Toro
Coupling of c-Src to large conductance voltage- and Ca2+-activated K+ channels as a new mechanism of agonist-induced vasoconstriction
PNAS,
October 29, 2002;
99(22):
14560 - 14565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-H. Lin, H. Sterling, K. M. Lerea, P. Welling, L. Jin, G. Giebisch, and W.-H. Wang
K depletion increases protein tyrosine kinase-mediated phosphorylation of ROMK
Am J Physiol Renal Physiol,
October 1, 2002;
283(4):
F671 - F677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Strauss, R. Rosenthal, D. Dey, J. Beninde, G. Wollmann, H. Thieme, and M. Wiederholt
Effects of Protein Kinase C on Delayed Rectifier K+ Channel Regulation by Tyrosine Kinase in Rat Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci.,
May 1, 2002;
43(5):
1645 - 1654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Boettger, S. Till, M. X. Chen, U. Anand, W. R. Otto, C. Plumpton, D. J. Trezise, S. N. Tate, C. Bountra, K. Coward, et al.
Calcium-activated potassium channel SK1- and IK1-like immunoreactivity in injured human sensory neurones and its regulation by neurotrophic factors
Brain,
February 1, 2002;
125(2):
252 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Davis, X. Wu, T. R. Nurkiewicz, J. Kawasaki, P. Gui, M. A. Hill, and E. Wilson
Regulation of ion channels by protein tyrosine phosphorylation
Am J Physiol Heart Circ Physiol,
November 1, 2001;
281(5):
H1835 - H1862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-M. Gu, Y. Wei, J. R. Falck, U. M. Krishna, and W.-H. Wang
Effects of protein tyrosine kinase and protein tyrosine phosphatase on apical K+ channels in the TAL
Am J Physiol Cell Physiol,
October 1, 2001;
281(4):
C1188 - C1195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy
Prolactin: Structure, Function, and Regulation of Secretion
Physiol Rev,
October 1, 2000;
80(4):
1523 - 1631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M. Shuba, N. Prevarskaya, L. Lemonnier, F. Van Coppenolle, P. G. Kostyuk, B. Mauroy, and R. Skryma
Volume-regulated chloride conductance in the LNCaP human prostate cancer cell line
Am J Physiol Cell Physiol,
October 1, 2000;
279(4):
C1144 - C1154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Skryma, P. Mariot, X. Le Bourhis, F. Van Coppenolle, Y. Shuba, F. V. Abeele, G. Legrand, S. Humez, B. Boilly, and N. Prevarskaya
Store depletion and store-operated Ca2+ current in human prostate cancer LNCaP cells: involvement in apoptosis
J. Physiol.,
August 15, 2000;
527(1):
71 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Kieffer and J. F. Habener
The adipoinsular axis: effects of leptin on pancreatic beta -cells
Am J Physiol Endocrinol Metab,
January 1, 2000;
278(1):
E1 - E14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Hein, J. C. Liao, and L. Kuo
oxLDL specifically impairs endothelium-dependent, NO-mediated dilation of coronary arterioles
Am J Physiol Heart Circ Physiol,
January 1, 2000;
278(1):
H175 - H183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Wang, K. M. Lerea, M. Chan, and G. Giebisch
Protein tyrosine kinase regulates the number of renal secretory K channels
Am J Physiol Renal Physiol,
January 1, 2000;
278(1):
F165 - F171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tian, J. A C Philp, and M. J Shipston
Glucocorticoid block of protein kinase C signalling in mouse pituitary corticotroph AtT20 D16:16 cells
J. Physiol.,
May 1, 1999;
516(3):
757 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Zegarra-Moran, A. Rasola, M. Rugolo, A. M. Porcelli, B. Rossi, and L. J. V. Galietta
HIV-1 Nef Expression Inhibits the Activity of a Ca2+-Dependent K+ Channel Involved in the Control of the Resting Potential in CEM Lymphocytes
J. Immunol.,
May 1, 1999;
162(9):
5359 - 5366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fukao, H. S. Mason, F. C. Britton, J. L. Kenyon, B. Horowitz, and K. D. Keef
Cyclic GMP-dependent Protein Kinase Activates Cloned BKCa Channels Expressed in Mammalian Cells by Direct Phosphorylation at Serine 1072
J. Biol. Chem.,
April 16, 1999;
274(16):
10927 - 10935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Takeuchi, M. Kishi, N. Hirayama, M. Yamaji, T. Ishii, H. Nishio, F. Hata, and T. Takewaki
Tyrosine kinase involvement in apamin-sensitive inhibitory responses of rat distal colon
J. Physiol.,
January 1, 1999;
514(1):
177 - 188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Sorin, O. Goupille, A. M. Vacher, J. Paly, J. Djiane, and P. Vacher
Distinct Cytoplasmic Regions of the Prolactin Receptor Are Required for Prolactin-induced Calcium Entry
J. Biol. Chem.,
October 23, 1998;
273(43):
28461 - 28469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Harvey and M L J Ashford
Role of tyrosine phosphorylation in leptin activation of ATP-sensitive K+ channels in the rat insulinoma cell line CRI-G1
J. Physiol.,
July 1, 1998;
510(1):
47 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Fadool, T. C. Holmes, K. Berman, D. Dagan, and I. B. Levitan
Tyrosine Phosphorylation Modulates Current Amplitude and Kinetics of a Neuronal Voltage-Gated Potassium Channel
J Neurophysiol,
September 1, 1997;
78(3):
1563 - 1573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Amsterdam and N. Selvaraj
Control of Differentiation, Transformation, and Apoptosis in Granulosa Cells by Oncogenes, Oncoviruses, and Tumor Suppressor Genes
Endocr. Rev.,
August 1, 1997;
18(4):
435 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Holm, P. Christophersen, S. P. Olesen, and S. Gammeltoft
Activation of calcium-dependent potassium channels in rat brain neurons by neurotrophin-3 and nerve growth factor
PNAS,
February 4, 1997;
94(3):
1002 - 1006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wei, P. Bloom, R. Gu, and W. Wang
Protein-tyrosine Phosphatase Reduces the Number of Apical Small Conductance K+ Channels in the Rat Cortical Collecting Duct
J. Biol. Chem.,
June 30, 2000;
275(27):
20502 - 20507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Moral, K. Dong, Y. Wei, H. Sterling, H. Deng, S. Ali, R. Gu, X.-Y. Huang, S. C. Hebert, G. Giebisch, et al.
Regulation of ROMK1 Channels by Protein-tyrosine Kinase and -tyrosine Phosphatase
J. Biol. Chem.,
March 2, 2001;
276(10):
7156 - 7163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sarkar, B. P. Pollack, K.-T. Lin, S. V. Kotenko, J. R. Cook, A. Lewis, and S. Pestka
hTid-1, a Human DnaJ Protein, Modulates the Interferon Signaling Pathway
J. Biol. Chem.,
December 21, 2001;
276(52):
49034 - 49042.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|